Screening for Dysbetalipoproteinemia by Plasma Cholesterol and Apolipoprotein B Concentrations
Open Access
- 1 May 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (5) , 904-907
- https://doi.org/10.1373/clinchem.2004.047001
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic riskThe American Journal of Cardiology, 2003
- Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemiaJournal of Lipid Research, 2003
- Direct Measurement of Low-Density-Lipoprotein Cholesterol Is More Effective Than Total Cholesterol for the Purpose of Lipoprotein ScreeningPreventive Medicine, 2001
- Apo E variants in patients with type III hyperlipoproteinemiaAtherosclerosis, 1996
- Apolipoprotein E to B Ratio: A Marker for Type III Hyperlipoproteinaemiacclm, 1993
- Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell BiologyScience, 1988
- A longitudinal assessment of lipid ratios in the diagnosis of type III hyperlipoproteinaemiaClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- The Biochemical, Clinical, and Genetic Features of Type III HyperlipoproteinemiaAnnals of Internal Medicine, 1975
- Type III Hyperlipoproteinemia: An Analysis of Two Contemporary DefinitionsAnnals of Internal Medicine, 1975
- Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (Type III hyperlipoproteinemia)Metabolism, 1972